HBE Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
HBE Wealth Management's BMY Position: Q3 2026 in Review
HBE Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.61% in Q3 2026, buying an estimated $1.39K and bringing the position to 3,633 shares worth $227K. The position accounts for 0.16% of the portfolio, ranked #50.
HBE Wealth Management first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 2,568 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- HBE Wealth Management held 3,633 shares of Bristol-Myers Squibb worth $227K as of Q3 2026.
- HBE Wealth Management bought 22 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.39K.
- Bristol-Myers Squibb made up 0.16% of HBE Wealth Management's portfolio in Q3 2026, its #50 holding.
- HBE Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
- 2,568 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on HBE Wealth Management's 13F filing for Q3 2026, filed 6 Nov 2026.